A COVID nasal vaccine based on technology developed at Washington University in St. Louis may soon be available in the U.S., Europe and Japan. Researchers say the vaccine may provide greater protection by delivering an immunity boost in the nose and upper respiratory area where the virus enters the body. For more details, click on link below